This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Here's Why You Should Add Solventum Stock to Your Portfolio Now
by Zacks Equity Research
SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
CAHPositive Net Change PACBPositive Net Change PAHCPositive Net Change SOLVNegative Net Change
medical medical-devices
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform
by Debanjana Dey
HIMS is building a data-driven care platform, adding Labs and multi-cancer testing to personalize treatment via continuous monitoring insights.
HIMSPositive Net Change DOCSPositive Net Change TEMNegative Net Change
medical medical-devices
Quest Diagnostics' Q1 Earnings & Revenues Top Estimates, Stock Up
by Zacks Equity Research
DGX posts Q1 2026 earnings and revenue beat, with adjusted EPS up 13% and shares rising in pre-market trading.
DGXNegative Net Change GMEDPositive Net Change PAHCPositive Net Change TCMDNegative Net Change
earnings medical medical-devices
Labcorp Gears Up to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
LH heads into Q1 earnings results with rising diagnostics demand, new partnerships, and AI-driven tools boosting growth across testing and consumer health.
LHNegative Net Change AGENNegative Net Change ENSGNegative Net Change TXGPositive Net Change
earnings medical medical-devices
Here Are 3 Medical Supply Stocks to Consider Amid Rising Prospects
by Indrajit Bandyopadhyay
Here, we highlight three dental supplies stocks, CAH, COO and BDX, which are well positioned to generate wealth for investors amid macro uncertainty.
CAHPositive Net Change BDXPositive Net Change COONegative Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in Concentra Group Stock?
by Zacks Equity Research
Investors need to pay close attention to CON stock based on the movements in the options market lately.
CONPositive Net Change
medical medical-devices
GEHC & DeepHealth Advance AI Breast Cancer Screening Globally
by Zacks Equity Research
GE HealthCare expands DeepHealth tie-up to roll out AI-powered mammography tools, improving early breast cancer detection and advancing women's health.
CAHPositive Net Change PACBPositive Net Change PAHCPositive Net Change GEHCPositive Net Change
medical medical-devices
10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced
by Zacks Equity Research
TXG stock jumps after unveiling Atera, a next-gen spatial biology platform aiming to scale single-cell analysis and deepen its role in drug discovery and research.
CAHPositive Net Change PAHCPositive Net Change TXGPositive Net Change GEHCPositive Net Change
medical medical-devices
Here's How Zimmer Biomet Is Placed Ahead of Q1 Earnings
by Zacks Equity Research
ZBH heads into Q1 results with steady EPS estimates, strong knee/hip demand trends and robotics momentum.
AGENNegative Net Change ENSGNegative Net Change ZBHPositive Net Change TXGPositive Net Change
earnings medical medical-devices
ISRG's Rising Procedure TAM With Low Penetration Backs Sustained Growth
by Indrajit Bandyopadhyay
ISRG expects its addressable procedures to reach 9 million by 2026, pointing to a significant growth runway as robotic surgery adoption remains nascent.
ABTNegative Net Change MDTNegative Net Change ISRGPositive Net Change
medical medical-devices